semustine has been researched along with Bile Duct Cancer in 1 studies
Semustine: 4-Methyl derivative of LOMUSTINE; (CCNU). An antineoplastic agent which functions as an alkylating agent.
semustine : An organochlorine compound that is urea in which the two hydrogens on one of the amino groups are replaced by nitroso and 2-chloroethyl groups and one hydrogen from the other amino group is replaced by a 4-methylcyclohexyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Three of 34 patients with bile duct cancer (1/12 [8%] on 5-FU, 0/10 on 5-FU + Stz, and 2/12 on 5-FU + MeCCNU) had objective response to treatment." | 2.65 | Eastern Cooperative Oncology Group experience with chemotherapy for inoperable gallbladder and bile duct cancer. ( Falkson, G; MacIntyre, JM; Moertel, CG, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Falkson, G | 1 |
| MacIntyre, JM | 1 |
| Moertel, CG | 1 |
1 trial available for semustine and Bile Duct Cancer
| Article | Year |
|---|---|
Eastern Cooperative Oncology Group experience with chemotherapy for inoperable gallbladder and bile duct cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Clinical Trials as Topic; Femal | 1984 |